Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.nantod.2020.101019 http://scihub22266oqcxt.onion/10.1016/j.nantod.2020.101019 33178330!7640897!33178330     free     free     free       Nano+Today 2021 ; 36 (ä): 101019 Nephropedia Template TP {{tp|p=33178330|t=2021. Insights from nanotechnology in COVID-19 treatment |pdf=|usr=}}{{33178330}} gab.com Text Insights from nanotechnology in COVID-19 treatment JO: Nano Today http://www.kidney.de/pget.php?&tw=1&pmid=33178330 #FOAvip In just a few months, SARS-CoV-2 and the disease it causes, COVID-19, created a worldwide pandemic. Virologists, biologists, pharmacists, materials scientists, and clinicians are collaborating to develop efficient treatment strategies. Overall, in addition to the use of clinical equipment to assist patient rehabilitation, antiviral drugs and vaccines are the areas of greatest focus. Given the physical size of SARS-CoV-2 and the vaccine delivery platforms currently in clinical trials, the relevance of nanotechnology is clear, and previous antiviral research using nanomaterials also supports this connection. Herein we briefly summarize current representative strategies regarding nanomaterials in antiviral research. We focus specifically on SARS-CoV-2 and the detailed role that nanotechnology can play in addressing this pandemic, including i) using FDA-approved nanomaterials for drug/vaccine delivery, including further exploration of the inhalation pathway; ii) introducing promising nanomaterials currently in clinical trials for drug/vaccine delivery; iii) designing novel biocompatible nanomaterials to combat the virus via interfering in its life cycle; and iv) promoting the utilization of nanomaterials in pneumonia treatment. Twit Text FOAVip Insights from nanotechnology in COVID-19 treatment ????Nano Today http://www.kidney.de/pget.php?&tw=1&pmid=33178330 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33178330 #FOAvip English Wikipedia <ref>{{Cite pmid|33178330}}</ref> Insights from nanotechnology in COVID-19 treatment #MMPMID33178330 Tang Z; Zhang X; Shu Y; Guo M; Zhang H; Tao W Nano Today 2021[Feb]; 36 (ä): 101019 PMID33178330show ga In just a few months, SARS-CoV-2 and the disease it causes, COVID-19, created a worldwide pandemic. Virologists, biologists, pharmacists, materials scientists, and clinicians are collaborating to develop efficient treatment strategies. Overall, in addition to the use of clinical equipment to assist patient rehabilitation, antiviral drugs and vaccines are the areas of greatest focus. Given the physical size of SARS-CoV-2 and the vaccine delivery platforms currently in clinical trials, the relevance of nanotechnology is clear, and previous antiviral research using nanomaterials also supports this connection. Herein we briefly summarize current representative strategies regarding nanomaterials in antiviral research. We focus specifically on SARS-CoV-2 and the detailed role that nanotechnology can play in addressing this pandemic, including i) using FDA-approved nanomaterials for drug/vaccine delivery, including further exploration of the inhalation pathway; ii) introducing promising nanomaterials currently in clinical trials for drug/vaccine delivery; iii) designing novel biocompatible nanomaterials to combat the virus via interfering in its life cycle; and iv) promoting the utilization of nanomaterials in pneumonia treatment. äInsights from nanotechnology in COVID-19 treatment (epmc).pdf DeepDyve Pubget Overpricing